Correction to: Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel
1 Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, P.O. Box 23, Belgrade, 11010, Serbia.
2 Emergency Department, Clinic for Cardiology, Clinical Center of Serbia, Belgrade, Serbia.
3 Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
4 Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, P.O. Box 23, Belgrade, 11010, Serbia. lili@imgge.bg.ac.rs.